Kash Patel Becomes the Focus of Media Analysis They Consistently Get Wrong
The Deplorable Treatment of Afghan Women Is a Glimpse Into Our Future
In Record Time, Voters Are Regretting Electing Socialist Mamdani
Steven Spielberg Flees California Before Its Billionaire Wealth Tax Fleeces Him
Oklahoma Bill Would Mandate Gun Safety Training in Public Schools
Here Is the Silver Lining to the Supreme Court's Tariff Ruling
CA Bends the Knee, Newsom Will Now Mandate English Proficiency Tests for Truck...
Guatemalan Citizen Admits Using Stolen Identity to Obtain Custody of Teen Migrant
Oregon-Based Utility PacifiCorp Settles for $575M Over Six Devastating Wildfires
Armed Man Rammed Substation Near Las Vegas in Apparent Terror Plot Before Committing...
DOJ Moves to Strip U.S. Citizenship From Former North Miami Mayor Over Immigration...
DOJ Probes Three Michigan School Districts That Allegedly Teach Gender Ideology
5th Circuit Vacates Ruling That Blocked Louisiana's Mandate to Display 10 Commandments in...
Kansas Engineer Gets 29 Months for $1.2M Kickback Scheme on Nuclear Weapons Projects
DOJ Files Antitrust Lawsuit Against Ohio Healthcare Company
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’
AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos